Tezusomant

Tezusomant is a growth hormone receptor antagonist. Tezusomant is promising for research of diseases such as acromegaly caused by excessive growth hormone secretion[1].

2802416-72-2

12352209

GHSR

GPCR/G Protein

Endocrinology

O=C1[C@]2([H])CC3=CN(CC(NCCCC[C@](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2)=O)CC(N)=O)=O)CO)=O)C(C)C)=O)C(C)C)=O)([H])N(C([C@@H](NC(CSC[C@H](NC([C@@H](NC(C(C)(NC([C@@H](NC([C@@H](NC([C@@H](N1)CC4=CC=C(C=C4)C(O)=O)=O)CCCCN)=O)CC(C5=C6)=CNC5=CC=C6O)=O)C)=O)C(C)C)=O)C(NCCCC[C@@H](C(N)=O)NC(CC[C@@H](C(O)=O)NC(CC[C@@H](C(O)=O)NC(CCCCCCCCCCCCCCC(O)=O)=O)=O)=O)=O)=O)CC7=CC=C(C=C7)C(O)=O)=O)C)=O)C8=C3C=CC=C8

C120H171N23O32S

2479.84

[1]communes internationales des Substances D. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2016, 30 (3) .

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P10964/

Peptides

No Development Reported